| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |